Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report

Interstitial pneumonitis is a rare but potentially fatal side effect occurring from 2 weeks to 16 weeks after the initiation of treatment with pegylated interferon alpha and ribavirin for chronic hepatitis C. Herein, we present a 68-year-old man with chronic hepatitis C virus infection who developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Atug, Ozlen, Akin, Hakan, Alahdab, Yesim Ozen, Ceyhan, Berrin, Tozun, Nurdan, Ozdogan, Osman
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827138/
https://www.ncbi.nlm.nih.gov/pubmed/20181162
http://dx.doi.org/10.1186/1757-1626-2-6464
_version_ 1782177915439415296
author Atug, Ozlen
Akin, Hakan
Alahdab, Yesim Ozen
Ceyhan, Berrin
Tozun, Nurdan
Ozdogan, Osman
author_facet Atug, Ozlen
Akin, Hakan
Alahdab, Yesim Ozen
Ceyhan, Berrin
Tozun, Nurdan
Ozdogan, Osman
author_sort Atug, Ozlen
collection PubMed
description Interstitial pneumonitis is a rare but potentially fatal side effect occurring from 2 weeks to 16 weeks after the initiation of treatment with pegylated interferon alpha and ribavirin for chronic hepatitis C. Herein, we present a 68-year-old man with chronic hepatitis C virus infection who developed interstitial pneumonitis association with pegylated interferon after 36 weeks initiation of pegylated interferon-alpha and ribavirin therapy. He did not recover after discontinuation of pegylated interferon/ribavirin and improved by steroid therapy.
format Text
id pubmed-2827138
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28271382010-02-24 Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report Atug, Ozlen Akin, Hakan Alahdab, Yesim Ozen Ceyhan, Berrin Tozun, Nurdan Ozdogan, Osman Cases J Research article Interstitial pneumonitis is a rare but potentially fatal side effect occurring from 2 weeks to 16 weeks after the initiation of treatment with pegylated interferon alpha and ribavirin for chronic hepatitis C. Herein, we present a 68-year-old man with chronic hepatitis C virus infection who developed interstitial pneumonitis association with pegylated interferon after 36 weeks initiation of pegylated interferon-alpha and ribavirin therapy. He did not recover after discontinuation of pegylated interferon/ribavirin and improved by steroid therapy. BioMed Central 2009-03-10 /pmc/articles/PMC2827138/ /pubmed/20181162 http://dx.doi.org/10.1186/1757-1626-2-6464 Text en Copyright ©2009 Atug et al; licensee Cases Network Ltd. licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Atug, Ozlen
Akin, Hakan
Alahdab, Yesim Ozen
Ceyhan, Berrin
Tozun, Nurdan
Ozdogan, Osman
Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report
title Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report
title_full Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report
title_fullStr Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report
title_full_unstemmed Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report
title_short Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report
title_sort interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis c infection: a case report
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827138/
https://www.ncbi.nlm.nih.gov/pubmed/20181162
http://dx.doi.org/10.1186/1757-1626-2-6464
work_keys_str_mv AT atugozlen interstitialpneumonitisassociatedwithpegylatedinterferonalpha2aandribavirinforchronichepatitiscinfectionacasereport
AT akinhakan interstitialpneumonitisassociatedwithpegylatedinterferonalpha2aandribavirinforchronichepatitiscinfectionacasereport
AT alahdabyesimozen interstitialpneumonitisassociatedwithpegylatedinterferonalpha2aandribavirinforchronichepatitiscinfectionacasereport
AT ceyhanberrin interstitialpneumonitisassociatedwithpegylatedinterferonalpha2aandribavirinforchronichepatitiscinfectionacasereport
AT tozunnurdan interstitialpneumonitisassociatedwithpegylatedinterferonalpha2aandribavirinforchronichepatitiscinfectionacasereport
AT ozdoganosman interstitialpneumonitisassociatedwithpegylatedinterferonalpha2aandribavirinforchronichepatitiscinfectionacasereport

Ejemplares similares